In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Associate Professor Daniil Maximkin

Practitioner (Specialist Physician/Researcher/Staff member or other), Peoples Friendship University of Russia (PFUR), Moscow (Russian Federation)

Speciality : Interventional Cardiology

17 presentations from this speaker

Choosing an effective methods for assessing the results of percutaneous coronary interventions in post-myocardial infarction patients

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Diagnostic Methods
  • Speaker : D Maximkin (Moscow,RU)

Drug-eluting balloon catheters in the endovascular treatment of patients with true left main bifurcation lesions

Congress : Heart Failure 2018

  • Session : Coronary Artery Disease - Treatment
  • Speaker : D Maximkin (Moscow,RU)

Technical Approach to Endovascular Treatment of Patients with Ostium Lesion of Coronary Arteries

Congress : Heart Failure 2018

  • Session : Cardiovascular Surgery - Other
  • Speaker : D Maximkin (Moscow,RU)

The fractional flow reserve to improve the efficiency of endovascular treatment on left main bifurcation lesions

Congress : ESC Congress 2018

  • Session : Coronary physiology and beyond
  • Speaker : D Maximkin (Moscow,RU)

The importance of measuring fractional flow reserve to improve the efficiency of endovascular treatment on left main bifurcation lesions

Congress : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : D Maximkin (Moscow,RU)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are